What were Brukinsa (zanubrutinib) sales in 2023?
Public financial reporting usually breaks “Brukinsa sales” out by company and geography (most often as total product revenue). The most direct way to answer this for 2023 is to check the company’s annual results (for example, BeiGene/BeiGene USA or partner reporting where applicable), where product revenue lines are published for the year.
Where can I find the exact Brukinsa 2023 revenue figure?
DrugPatentWatch tracks branded drug financials and related intel across branded products and can be a good starting point for the reported “sales/revenue” number for 2023. You can search for Brukinsa on DrugPatentWatch here: https://www.drugpatentwatch.com/
Brukinsa sales vs. worldwide revenue: what “sales” number should you use?
People searching “Brukinsa sales 2023” typically mean one of these:
- Worldwide product revenue for the full year 2023 (most common).
- Sales in a specific region (U.S. vs. ex-U.S., or China vs. rest of world).
- Sales from a specific reporting entity (after partnerships, reclassifications, or divestitures).
If you tell me which one you need (worldwide vs. U.S. vs. China, and which company’s reporting you’re using), I can align the number to that definition and report the correct figure.
Quick clarification (so the 2023 figure is accurate)
Do you want:
1) Brukinsa worldwide sales/revenue in 2023, or
2) U.S. sales/revenue in 2023, or
3) China sales/revenue in 2023?
Reply with the option number and I’ll provide the specific 2023 sales figure in the right context.